reference/18564901

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18564901

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	652
issn	0006-3223
issueIdentifier	7
pageRange	644-652
publicationName	Biological Psychiatry
startingPage	644
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ca36808bcd0e006e6321fc30b825e895 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d435cdbf64a083c70b58203182274e02 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_343bf067bc73bcc16dcec46d6271615e
bibliographicCitation	Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, Plotnicov KH, Weise J, Deep D. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001 Apr 01;49(7):644–52. doi: 10.1016/s0006-3223(00)01013-1. PMID: 11297722.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7076c4ac1fdca749ff49890724802fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9178a03313cf6aed55c4dce78a975a68 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed01e5c9cb2ce1d1f97a41b5a11e2403 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70b956409aab046c1c5b9df6f1fd0bef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31b11db1d6ebe01b5a24e12c3d0c6acd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f25dd8e14bde38a73f0cf8b811915a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fb51ed621631b4e1811281ece70ba40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af77cf411b8b167bc46df5f290fd5258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c561de020585203fcb0a3c3701039880
date	2001-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/11297722 https://doi.org/10.1016/s0006-3223%2800%2901013-1
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1117 https://portal.issn.org/resource/ISSN/0006-3223
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa
discusses	http://id.nlm.nih.gov/mesh/M0026372 http://id.nlm.nih.gov/mesh/M0008635
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000856Q000188 http://id.nlm.nih.gov/mesh/D017367Q000627 http://id.nlm.nih.gov/mesh/D005473Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015430 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D005473Q000008 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D017367Q000008 http://id.nlm.nih.gov/mesh/D055502 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_efdbbf9d9f20cdf89f19d5cc9171b33b

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129178651 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671

Total number of triples: 53.